News

Click here to sign up to the OPDC News Mailing list

OPDC researcher Simon Lovestone knighted in Queen’s Birthday honours

OPDC researcher Simon Lovestone knighted in Queen’s Birthday honours

Posted 22/06/2017

Dr Lovestone is a practising Old Age Psychiatrist who has been recognised for his services to neuroscience research. His research focuses on the regulation of tau phosphorylation, the search for genetic and other biomarkers of Alzheimer’s disease and, building on these, on drug discovery and experimental medicine. Underpinning all these studies is the use of informatics - clinical informatics, bioinformatics and the challenges of extracting ...

OPDC researchers honoured at teaching award ceremony

OPDC researchers honoured at teaching award ceremony

Posted 05/06/2017

Researchers at OPDC were selected as finalists at the 2017 Oxford University Students’ Union Teaching awards.  There were 895 nominations for this year’s awards. Every single nomination highlighted an example of exceptional effort and talent, and every nominee deserves to be recognised for their achievements. Dr Siddharth Arora, who works on OPDC’s smartphone project, was the winner of the Most Acclaimed Lecturer Award for the division of ...

OPDC scientist Dr Ludovica Griffanti talks about her research in the pub at sell-out event

OPDC scientist Dr Ludovica Griffanti talks about her research in the pub at sell-out event

Posted 24/05/2017

This May, Dr Ludovica Griffanti was among scientists who spoke at the sell-out Beautiful Minds session at the St Aldates Tavern, Oxford. The event was part of the Pint of Science series which brings some of the most brilliant scientists to local pubs to discuss their latest research and findings. Dr Griffanti is a researcher with OPDC at the Oxford Centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB). Her talk dealt with her ...

Mission Therapeutics and OPDC PI Richard Wade-Martins awarded research grant from the Michael J. Fox Foundation

Mission Therapeutics and OPDC PI Richard Wade-Martins awarded research grant from the Michael J. Fox Foundation

Posted 11/04/2017

Mission Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes (DUBs) to treat neurodegenerative diseases, cancer and other diseases with high unmet medical need, announced that it has been awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research (MJFF). This research grant, announced on World Parkinson’s day, will support the testing of Mission Therapeutics’ potent ...

OPDC Investigator heads up new consortium to investigate aggregated proteins in Alzheimer’s and Parkinson’s

OPDC Investigator heads up new consortium to investigate aggregated proteins in Alzheimer’s and Parkinson’s

Posted 10/04/2017

The Innovative Medicines Initiative (IMI) launched IMPRiND in March 2017, an innovative research project that is devoted to investigating whether mechanisms of propagation of aggregated proteins between cells could enable novel therapeutic approaches in Alzheimer’s and Parkinson’s. Alzheimer’s and Parkinson’s are age-related neurodegenerative disorders without cure. They are characterised by the progressive loss of brain cells often along ...

Monique from our OPDC cohort on her experiences

Monique from our OPDC cohort on her experiences

Posted 09/02/2017

Here OPDC participant talks about why being part of such a vast project is very exciting.

"At a time in my life when I cannot do what I used to, taking part in health research gives me a sense of purpose and of still belonging to society and playing my part. It keeps my brain going and gives me hope that one day other people like us, their families and friends will benefit from the results. I have no doubt participating in these studies has helped my confidence"
New way of repurposing drugs could lead to better Parkinson’s treatments

New way of repurposing drugs could lead to better Parkinson’s treatments

Posted 19/01/2017

By bringing together cutting-edge stem cell technologies and computational biology, researchers at OPDC have developed a unique way to identify existing drugs that could potentially be repurposed for treating Parkinson’s. This promising research, published in the journal Human Molecular Genetics, uses a stem cell technique to turn a small piece of skin from people with Parkinson’s into dopamine-producing brain cells – identical to those that ...

OPDC researchers in new drug trial for Parkinson's

OPDC researchers in new drug trial for Parkinson's

Posted 12/01/2017

Our researchers have been granted 600K euros from EU’s Horizon 2020 Framework Programme to join in a multi-centre initiative studying a new drug for Parkinson’s.  The three-year project for Laura Parkkinen’s group is part of the first clinical study of CDNF (Cerebral Dopamine Neurotrophic Factor) in Parkinson's. CDNF, patented worldwide by Herantis Pharma, a Finnish pharmaceutical company, will be administered directly into the brains of 18 ...

OPDC researchers on BBC news

OPDC researchers on BBC news

Posted 15/12/2016

OPDC Clinical Research Fellow Dr Tom Barber recently spoke with BBC Oxford's David Prever about his research into REM sleep behaviour disorder (RBD) and the need to more people to join our study. REM sleep disorder is a condition where people act out nightmares in their sleep. Dr Barber discusses the need for more people with the sleep disorder to join our study and also how we are in need of healthy male volunteers over 50 to join as a control ...

Award for Paul Mayhew Archer's documentary 'the funny side of Parkinson's' featuring OPDC research

Award for Paul Mayhew Archer's documentary 'the funny side of Parkinson's' featuring OPDC research

Posted 09/11/2016

Paul Mayhew-Archer has been named best presenter at the Grierson Awards, which celebrate Britain’s best documentaries. 

Parkinson's: The Funny Side was a rare venture in front of the camera for the man who has written on Miranda, My Hero and Mrs Brown's Boys, as well as The Vicar of Dibley with Richard Curtis. The programme features Dr Fahd Baig, OPDC Clinical Research Fellow, talking to Paul about the phone app that is used in our large Discovery Cohort Study, and Professor Richard Wade-Martins, OPDC Principal Investigator, giving a summary of our research at the OPDC.